Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal MEDICINUS
Ana Widyaningsih
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Neuroscience Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Peran Krusial Farmakovigilans dalam Meningkatkan Keamanan Pasien (Patient Safety) Ana Widyaningsih
MEDICINUS Vol. 38 No. 9 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/zrh11y34

Abstract

Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse drug effects or other drug-related problems. The importance of drug safety monitoring stemmed from the thalidomide tragedy, which led to the formation of international programs to strengthen the regulatory framework on drug safety. Drug safety evaluation is conducted through a series of testing stages before a drug is marketed. However, pharmacovigilance activities performed post-marketing are crucial for detecting rare side effects that could not be identified during the pre-marketing testing phases. Multisectoral collaboration among various relevant parties and stakeholders is vital for the success of pharmacovigilance, with the ultimate goal of ensuring the safe use of medicines and patient safety.
Co-Authors